Use of Nakanuma staging and cytokeratin 7 staining for diagnosing recurrent primary biliary cholangitis after living‐donor liver transplantation
- 18 December 2019
- journal article
- research article
- Published by Wiley in Hepatology Research
- Vol. 50 (4), 478-487
- https://doi.org/10.1111/hepr.13476
Abstract
Aim Diagnosis of primary biliary cholangitis (PBC), which recurs in approximately 30% of liver transplant recipients, is histology‐based, but no staging system has been established for recurrent PBC (rPBC). We used the Nakanuma staging system and cytokeratin 7 (CK7) staining to examine post‐transplant liver biopsy specimens retrospectively and to evaluate histological features of rPBC. Methods From 107 patients who underwent living donor liver transplantation for PBC, 60 recipients with 214 liver biopsies after 1‐year post transplant were enrolled. Fibrosis, bile duct loss (BL), cholangitis activity, hepatitis activity, and CK7‐positive hepatocytes were scored. Nakanuma staging was based on fibrosis and BL scores. We examined the correlation of scores and clinicolaboratory data among rPBC patients. We also evaluated whether chronological change of stage was correlated with liver‐related failure. Results Of 214 biopsies, 52 were protocol biopsy; 162 were episodic. Higher BL, cholangitis activity, and hepatitis activity scores were associated with rPBC diagnosis. At median follow up of 10.0 years (range 1.4–18.7 years), 29 (48%) patients were diagnosed with rPBC at 4.6 years (range 1.3–14.5 years). Liver‐related failure occurred in five rPBC cases; three from rPBC, and two from chronic rejection. At rPBC diagnosis, higher BL and CK7 scores were more frequent in patients who developed liver‐related failure than in other patients (P = 0.04, P < 0.01, respectively). In failure patients, the Nakanuma stage increased over time, and reached up to stage 4, whereas the Scheuer stage did not reach above stage 3. Conclusions Nakanuma staging is associated with rPBC and disease progression. Scores for BL and CK7 might be early markers for progressive rPBC.Keywords
Funding Information
- Japan Society for the Promotion of Science (17H04095, 26460600)
This publication has 23 references indexed in Scilit:
- Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient SurvivalGastroenterology, 2019
- Disease recurrence plays a minor role as a cause for retransplantation after living‐donor liver transplantation for primary biliary cirrhosis: A multicenter study in JapanHepatology Research, 2012
- Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantationLiver Transplantation, 2007
- Recurrence of autoimmune liver disease after liver transplantation: A systematic reviewLiver Transplantation, 2006
- Liver biopsy interpretation for causes of late liver allograft dysfunctionJournal of Hepatology, 2006
- Recurrent primary biliary cirrhosisLiver Transplantation, 2003
- Disease recurrence after living liver transplantation for primary biliary cirrhosis: A clinical and histological follow-up studyLiver Transplantation, 2001
- Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single centerJournal of Hepatology, 2001
- Primary biliary cirrhosis: Histological evidence of disease recurrence after liver transplantationJournal of Hepatology, 1993
- Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)Virchows Archiv, 1978